Erasca, Inc.
Clinical trials sponsored by Erasca, Inc., explained in plain language.
-
First patients to try experimental cancer pill targeting tough tumors
Disease control Recruiting nowThis is the first study in humans testing a new oral cancer drug called ERAS-0015. Researchers want to find safe doses and see how the body processes the drug when given alone or with other treatments to 200 adults with advanced solid tumors that have spread and have specific RAS…
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients to try new pill targeting common cancer mutation
Disease control Recruiting nowThis is the first study in people to test a new oral drug called ERAS-4001. It aims to find a safe dose and see how the body handles the drug in patients with advanced solid tumors that have specific KRAS mutations. The drug will be tested alone and in combination with other canc…
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC